EMALEX BIOSCIENCES

At Emalex Biosciences, we are working diligently to help people with TS find relief from tics that not only often cause pain and injury but also social stigma and emotional distress... Our leadership team is comprised of remarkable professionals who are passionate about innovative solutions that improve the lives of people living with chronic central nervous system conditions... Currently, we are investigating therapies for Tourette syndrome in pediatric patients and childhood-onset fluency disorder-also known as stuttering-in adults. To date, there is only one U.S. Food and Drug Administration (FDA)-approved treatment for Tourette's and no FDA-approved treatment for childhood-onset fluency disorder.

Also known as: Emalex Biosciences Inc.

Primary location: Chicago United States